Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

InfuSystems Holdings, Inc. (INFU) vs TriSalus Life Sciences, Inc. (TLSI)

InfuSystems Holdings, Inc. and TriSalus Life Sciences, Inc. are both Medical Devices companies. TriSalus Life Sciences, Inc. is the larger, with a market value of $303.6M against $252.8M — 1.2× the size. TriSalus Life Sciences, Inc. has negative trailing earnings, so its P/E is not meaningful; InfuSystems Holdings, Inc. trades at 30.3×. TriSalus Life Sciences, Inc. grew revenue faster over the last twelve months: 25.3% against 2.47%. InfuSystems Holdings, Inc. has the higher net margin (5.96% vs −127.0%) and the higher return on invested capital (10.6% vs 0.00%). Across the 18 metrics below, InfuSystems Holdings, Inc. leads on 12 and TriSalus Life Sciences, Inc. on 6.

Valuation

Metric INFU TLSI Medical Devices median
P/E 30.26 n/m 22.18
P/S 1.78 5.61 2.70
P/B 4.31 38.63 2.46
Price to free cash flow 118.93 n/m 22.53
EV/EBITDA 10.36 n/m 11.78
EV/Sales 1.92 5.33 2.38
Earnings yield 3.30% (29.95%) (8.22%)
Free cash flow yield 0.84% (9.48%) (7.80%)

Profitability

Metric INFU TLSI Medical Devices median
Gross margin 57.45% 85.79% 56.01%
Operating margin 9.26% (67.68%) (15.03%)
Net margin 5.96% (127.00%) (20.40%)
Free cash flow margin 10.56% (51.56%) (7.24%)
Return on equity 15.03% 889.44% (15.32%)
Return on assets 8.61% (110.34%) (19.72%)
Return on invested capital 10.55% 0.00% (10.33%)

Growth

Metric INFU TLSI Medical Devices median
Revenue growth (TTM) 2.47% 25.25% 8.80%
EPS growth (last fiscal year) 181.82% (40.46%) —
Revenue growth, 5-year CAGR 8.05% — 15.23%
Net income growth, 5-year CAGR (17.49%) 0.00% 0.00%

Health

Metric INFU TLSI Medical Devices median
Debt to equity 0.35 5.05 0.07
Current ratio 2.50 5.35 2.50
Net debt to EBITDA 0.65 (0.50) 0.49

Dividend

Metric INFU TLSI Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric INFU TLSI Medical Devices median
Market cap 252.75m 303.56m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack